These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28929869)

  • 1. Pharmacare: Are we getting the right medicines?
    Attara G
    Healthc Manage Forum; 2017 Jul; 30(4):193-196. PubMed ID: 28929869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health resource allocation. A made-in-Canada description.
    Noseworthy T
    J Leg Med; 2011 Jan; 32(1):11-26. PubMed ID: 21391053
    [No Abstract]   [Full Text] [Related]  

  • 3. Should national pharmacare apply a value-based insurance design?
    Yeung K; Morgan SG
    CMAJ; 2019 Jul; 191(29):E811-E815. PubMed ID: 31332049
    [No Abstract]   [Full Text] [Related]  

  • 4. Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.
    Morgan SG; Li W; Yau B; Persaud N
    CMAJ; 2017 Feb; 189(8):E295-E302. PubMed ID: 28246223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whither seniors' pharmacare: lessons from (and for) Canada.
    Morgan SG; Barer ML; Agnew JD
    Health Aff (Millwood); 2003; 22(3):49-59. PubMed ID: 12757272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-Romanow pharmacare: last-dollar first...first-dollar lost?
    Morgan SG; Willison DJ
    Healthc Pap; 2004; 4(3):10-20. PubMed ID: 15114064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. It Won't Be Easy: How to Make Universal Pharmacare Work in Canada.
    Lewis S
    Int J Health Policy Manag; 2020 Jan; 9(1):1-5. PubMed ID: 31902189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada".
    Gagnon MA
    Int J Health Policy Manag; 2021 Mar; 10(3):168-171. PubMed ID: 32610789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Policy choices for pharmacare; the need to examine benefit design, medication management strategies and evaluation.
    Sketris IS; Brown MG; Murphy AL
    Healthc Pap; 2004; 4(3):36-45; discussion 68-72. PubMed ID: 15114068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waiting lists not pharmacare main issue: feds.
    Sibbald B
    CMAJ; 2004 Sep; 171(6):559. PubMed ID: 15367451
    [No Abstract]   [Full Text] [Related]  

  • 11. National pharmacare: a dog's tale.
    Anis AH
    CMAJ; 2004 Sep; 171(6):565-6. PubMed ID: 15367455
    [No Abstract]   [Full Text] [Related]  

  • 12. Waiting for reimbursement of new medicines in Canada: it's time for a rethink.
    Skinner BJ
    Pharmacoeconomics; 2008; 26(8):629-32. PubMed ID: 18620457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter- and intraprovincial inequities in public coverage of cancer drug programs across Canada: a plea for the establishment of a pan-Canadian pharmacare program.
    Sorin M; Franco EL; Quesnel-Vallée A
    Curr Oncol; 2019 Aug; 26(4):266-269. PubMed ID: 31548806
    [No Abstract]   [Full Text] [Related]  

  • 14. Stitching the gaps in the Canadian public drug coverage patchwork?: a review of provincial pharmacare policy changes from 2000 to 2010.
    Daw JR; Morgan SG
    Health Policy; 2012 Jan; 104(1):19-26. PubMed ID: 21978939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal Pharmacare in Canada: A Prescription for Equity in Healthcare.
    Hajizadeh M; Edmonds S
    Int J Health Policy Manag; 2020 Mar; 9(3):91-95. PubMed ID: 32202091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can a health care system change?
    Lexchin J
    CMAJ; 1997 Sep; 157(5):507-8. PubMed ID: 9294383
    [No Abstract]   [Full Text] [Related]  

  • 17. Bonanza for drug companies. Quebec's public drug plan pays for biotechnology boom.
    Blair L
    Can Fam Physician; 2002 Apr; 48():831, 833, 836-8. PubMed ID: 12046376
    [No Abstract]   [Full Text] [Related]  

  • 18. Framing incremental expansions to public health insurance systems: the case of Canadian pharmacare.
    Daw JR; Morgan SG; Collins PA; Abelson J
    J Health Polit Policy Law; 2014 Apr; 39(2):295-330. PubMed ID: 24711215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare".
    Rawson NSB
    Int J Health Policy Manag; 2020 Dec; 9(12):524-527. PubMed ID: 32610769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canada can afford universal pharmacare – no more excuses.
    Stanbrook MB
    CMAJ; 2015 Apr; 187(7):475. PubMed ID: 25802314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.